Cochrane Abstracts
Hypothalamic‐pituitary‐adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Hypothalamic‐pituitary‐adrenal (HPA) Axis Suppression After Treatment With Glucocorticoid Therapy for Childhood Acute Lymphoblastic Leukaemia." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435037/1/Hypothalamic.
Hypothalamic‐pituitary‐adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435037/1/Hypothalamic. Accessed April 5, 2026.
Hypothalamic‐pituitary‐adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435037/1/Hypothalamic
Hypothalamic‐pituitary‐adrenal (HPA) Axis Suppression After Treatment With Glucocorticoid Therapy for Childhood Acute Lymphoblastic Leukaemia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 April 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435037/1/Hypothalamic.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Hypothalamic‐pituitary‐adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia
ID - 435037
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435037/1/Hypothalamic
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
